Roche Holding AG (RO.SW) News
Track canonical SquawkNews coverage tagged to RO.SW, Roche Holding AG. This hub brings together deduplicated headlines about swiss, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns
() -- Berenberg downgraded Qiagen (QIA.F) to hold from buy and reduced its price target to 40 euros from 50 euros, citing growing market pressure on its tuberculosis testing franchise and expectations of a slowdown in US
EARNINGS | Jul 15, 2026, 09:56 AM UTC
L
Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy
() -- Roche's (RO.SW) supplemental biologics license application for Gazyva/Gazyvaro received priority review from the US Food and Drug Administration for the treatment of primary membranous nephropathy, or pMN, a chroni
REGULATION | Jul 15, 2026, 05:39 AM UTC
H
Swiss Market Index Slips; Roche Shares Down
() -- Swiss stocks slipped into negative territory on Tuesday, with the Swiss Market Index closing 0.17% lower, as hostilities between the US and Iran further intensified. "The return of the US blockade [on Iran] is much
MACRO | Jul 14, 2026, 03:50 PM UTC